Nosarti Chiara, Roberts Jonathan V, Crayford Timothy, McKenzie Kwame, David Anthony S
Division of Psychological Medicine, Department of Psychiatry, The Guy's, King's and St. Thomas' School of Medicine and Institute of Psychiatry, De Crespigny Park, London, UK.
J Psychosom Res. 2002 Dec;53(6):1123-30. doi: 10.1016/s0022-3999(02)00350-1.
A significant proportion of breast cancer patients experiences psychiatric morbidity in the first year after a breast cancer diagnosis and/or beginning of treatment. This study attempted to identify and understand the risk factors for developing such problems.
A consecutive series of 87 patients, aged 40-75 years, was assessed prior to diagnosis of breast cancer and followed-up approximately 8 weeks after beginning of cancer treatment and again 9 months after first follow-up. Assessments included measures of psychiatric morbidity using the General Health Questionnaire (GHQ-12), coping style using the Mental Adjustment to Cancer (MAC) Scale, symptom attribution, beliefs about breast cancer, social support, socio-demographic and clinical variables.
A total of 85.1% of patients completed both follow-ups. Pre-diagnostically, 32.2% of breast cancer patients scored as a GHQ-12 'case.' GHQ scores fell significantly between pre-diagnostic and both post-diagnostic assessments, especially in women who had thought they had cancer. Predictors of psychological morbidity at first follow-up included pre-diagnostic GHQ-12 score, lack of social support and feelings of 'personal responsibility/avoidance.' GHQ-12 'caseness' at second follow-up was predicted by lack of social support alone.
Overall, psychiatric morbidity is higher prior to, than following, a definitive diagnosis of breast cancer. Early reactions of this kind are predictive of post-treatment adjustment. However, only the presence of social support in this study seems to be associated with successful adjustment in the first year following a breast cancer diagnosis. Women at increased risk of psychological morbidity after a breast cancer diagnosis may be thus identifiable and targeted therapeutically.
相当一部分乳腺癌患者在乳腺癌诊断和/或开始治疗后的第一年出现精神疾病。本研究试图确定并了解出现此类问题的风险因素。
对连续的87例年龄在40 - 75岁的患者在乳腺癌诊断前进行评估,并在开始癌症治疗后约8周以及首次随访后9个月进行随访。评估包括使用一般健康问卷(GHQ - 12)测量精神疾病、使用癌症心理调适(MAC)量表测量应对方式、症状归因、对乳腺癌的信念、社会支持、社会人口统计学和临床变量。
共有85.1%的患者完成了两次随访。在诊断前,32.2%的乳腺癌患者GHQ - 12得分被判定为“病例”。GHQ得分在诊断前和两次诊断后评估之间显著下降,尤其是那些认为自己患有癌症的女性。首次随访时心理疾病的预测因素包括诊断前GHQ - 12得分、缺乏社会支持以及“个人责任/回避”感。第二次随访时GHQ - 12“病例”情况仅由缺乏社会支持预测。
总体而言,乳腺癌确诊前的精神疾病发病率高于确诊后。这种早期反应可预测治疗后的调整情况。然而,在本研究中,似乎只有社会支持的存在与乳腺癌诊断后第一年的成功调整相关。因此,乳腺癌诊断后心理疾病风险增加的女性可能可以被识别出来并进行针对性治疗。